FI49522B - - Google Patents

Info

Publication number
FI49522B
FI49522B FI320171A FI320171A FI49522B FI 49522 B FI49522 B FI 49522B FI 320171 A FI320171 A FI 320171A FI 320171 A FI320171 A FI 320171A FI 49522 B FI49522 B FI 49522B
Authority
FI
Finland
Application number
FI320171A
Other languages
Finnish (fi)
Other versions
FI49522C (fi
Inventor
Bruce Wixson Calnek
Stephen Ballinger Hitchner
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of FI49522B publication Critical patent/FI49522B/fi
Publication of FI49522C publication Critical patent/FI49522C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255Marek's disease virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16311Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16311Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16351Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI320171A 1970-11-25 1971-11-09 Menetelmä stabiilin solu-vapaan viruspreparaatin valmistamiseksi FI49522C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9292070A 1970-11-25 1970-11-25
US17061671A 1971-08-10 1971-08-10

Publications (2)

Publication Number Publication Date
FI49522B true FI49522B (en:Method) 1975-04-01
FI49522C FI49522C (fi) 1975-07-10

Family

ID=26786189

Family Applications (1)

Application Number Title Priority Date Filing Date
FI320171A FI49522C (fi) 1970-11-25 1971-11-09 Menetelmä stabiilin solu-vapaan viruspreparaatin valmistamiseksi

Country Status (17)

Country Link
JP (1) JPS5750477B1 (en:Method)
AR (1) AR196979A1 (en:Method)
AU (1) AU473436B2 (en:Method)
BE (1) BE775747A (en:Method)
BR (1) BR7107679D0 (en:Method)
CA (1) CA935091A (en:Method)
CH (1) CH581193A5 (en:Method)
DE (1) DE2158293B2 (en:Method)
DK (1) DK130796B (en:Method)
FI (1) FI49522C (en:Method)
FR (1) FR2115379B1 (en:Method)
GB (1) GB1374123A (en:Method)
IE (1) IE35695B1 (en:Method)
IL (1) IL37849A (en:Method)
IT (1) IT1035519B (en:Method)
NL (1) NL7115348A (en:Method)
PH (1) PH11064A (en:Method)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT71926B (en) * 1979-10-29 1982-03-31 Merck & Co Inc Process for preparing a liquid vaccine comprising a stabilizer
GB2086408B (en) * 1980-10-16 1985-10-09 Oreal New nitro-derivatives of the benzene series the process for their preparation and their use in the dyeing of keratin fibres
DK331087A (da) * 1986-06-30 1987-12-31 Smith Kline Rit Stabilisator for levende vaccine
JPS62212326A (ja) * 1987-09-14 1987-09-18 Gen Corp:Kk マレツク病2価生ワクチンとその製造方法

Also Published As

Publication number Publication date
JPS5750477B1 (en:Method) 1982-10-27
IT1035519B (it) 1979-10-20
PH11064A (en) 1977-10-25
FI49522C (fi) 1975-07-10
IL37849A (en) 1975-04-25
AU3442071A (en) 1973-04-19
DK130796C (en:Method) 1975-10-06
FR2115379B1 (en:Method) 1977-01-07
NL7115348A (en:Method) 1972-05-29
DE2158293B2 (de) 1979-01-25
BR7107679D0 (pt) 1973-07-03
AR196979A1 (es) 1974-03-08
DE2158293A1 (de) 1972-06-08
CH581193A5 (en:Method) 1976-10-29
CA935091A (en) 1973-10-09
GB1374123A (en) 1974-11-13
BE775747A (fr) 1972-05-24
IE35695B1 (en) 1976-04-28
AU473436B2 (en) 1976-06-24
DK130796B (da) 1975-04-14
IE35695L (en) 1972-05-25
FR2115379A1 (en:Method) 1972-07-07
IL37849A0 (en) 1971-12-29

Similar Documents

Publication Publication Date Title
ATA96471A (en:Method)
AU1146470A (en:Method)
AU2044470A (en:Method)
AU1473870A (en:Method)
AU2130570A (en:Method)
AU2085370A (en:Method)
AU2017870A (en:Method)
AU1833270A (en:Method)
AU1716970A (en:Method)
AU1517670A (en:Method)
AU1336970A (en:Method)
AR195465A1 (en:Method)
AU1591370A (en:Method)
AU1841070A (en:Method)
AU2144270A (en:Method)
AU2131570A (en:Method)
AU2130770A (en:Method)
AU1328670A (en:Method)
AU1277070A (en:Method)
AU1343870A (en:Method)
ATA672271A (en:Method)
AU2119370A (en:Method)
AU1247570A (en:Method)
AU1581370A (en:Method)
AU1235770A (en:Method)